Your browser doesn't support javascript.
loading
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial.
Waibel, M; Thomas, H E; Wentworth, J M; Couper, J J; MacIsaac, R J; Cameron, F J; So, M; Krishnamurthy, B; Doyle, M C; Kay, T W.
Afiliação
  • Waibel M; St Vincent's Institute of Medical Research, Melbourne, Australia.
  • Thomas HE; St Vincent's Institute of Medical Research, Melbourne, Australia.
  • Wentworth JM; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, 3065, Australia.
  • Couper JJ; Wentworth Department of Medical Biology, The University of Melbourne, Parkville, Victoria, 3010, Australia.
  • MacIsaac RJ; The Royal Melbourne Hospital, Melbourne, Australia.
  • Cameron FJ; Robinson Research Institute, University of Adelaide and Women's and Children's Hospital, Adelaide, Australia.
  • So M; St Vincent's Hospital, Melbourne, Australia.
  • Krishnamurthy B; MacIsaac Department of Medicine, The University of Melbourne, Fitzroy, 3065, Australia.
  • Doyle MC; The Royal Children's Hospital, Melbourne, Australia.
  • Kay TW; St Vincent's Institute of Medical Research, Melbourne, Australia.
Trials ; 23(1): 433, 2022 May 23.
Article em En | MEDLINE | ID: mdl-35606820
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article